Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Volumes to learn: advancing therapeutics with innovative computed tomography image data analysis.

Literature DB >> 20643780

Volumes to learn: advancing therapeutics with innovative computed tomography image data analysis.

Abstract

Semi-automated methods for calculating tumor volumes from computed tomography images are a new tool for advancing the development of cancer therapeutics. Volumetric measurements, relying on already widely available standard clinical imaging techniques, could shorten the observation intervals needed to identify cohorts of patients sensitive or resistant to treatment. ©2010 AACR.

Entities: Chemical Disease Gene Species

Mesh：

Year: 2010 PMID： 20643780 PMCID： PMC3263311 DOI： 10.1158/1078-0432.CCR-10-1548

Source DB: PubMed Journal: Clin Cancer Res ISSN： 1078-0432 Impact factor: 12.531

12 in total

1. A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development.

Authors: Binsheng Zhao; Geoffrey R Oxnard; Chaya S Moskowitz; Mark G Kris; William Pao; Pingzhen Guo; Valerie M Rusch; Marc Ladanyi; Naiyer A Rizvi; Lawrence H Schwartz
Journal: Clin Cancer Res Date: 2010-06-09 Impact factor: 12.531

2. Lung cancer: computerized quantification of tumor response--initial results.

Authors: Binsheng Zhao; Lawrence H Schwartz; Chaya S Moskowitz; Michelle S Ginsberg; Naiyer A Rizvi; Mark G Kris
Journal: Radiology Date: 2006-12 Impact factor: 11.105

Review 3. Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence.

Authors: P D Mozley; L H Schwartz; C Bendtsen; B Zhao; N Petrick; A J Buckler
Journal: Ann Oncol Date: 2010-03-23 Impact factor: 32.976

4. Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug development.

Authors: Y Wang; C Sung; C Dartois; R Ramchandani; B P Booth; E Rock; J Gobburu
Journal: Clin Pharmacol Ther Date: 2009-05-13 Impact factor: 6.875

5. Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics.

Authors: Laurent Claret; Pascal Girard; Paulo M Hoff; Eric Van Cutsem; Klaas P Zuideveld; Karin Jorga; Jan Fagerberg; René Bruno
Journal: J Clin Oncol Date: 2009-07-27 Impact factor: 44.544

6. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006.

Authors: Michaela A Dinan; Lesley H Curtis; Bradley G Hammill; Edward F Patz; Amy P Abernethy; Alisa M Shea; Kevin A Schulman
Journal: JAMA Date: 2010-04-28 Impact factor: 56.272

7. Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.

Authors: Theodore G Karrison; Michael L Maitland; Walter M Stadler; Mark J Ratain
Journal: J Natl Cancer Inst Date: 2007-09-25 Impact factor: 13.506

8. An alternative model for the evaluation of antitumor activity.

Authors: P T Lavin
Journal: Cancer Clin Trials Date: 1981

9. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.

Authors: John J Bissler; Francis X McCormack; Lisa R Young; Jean M Elwing; Gail Chuck; Jennifer M Leonard; Vincent J Schmithorst; Tal Laor; Alan S Brody; Judy Bean; Shelia Salisbury; David N Franz
Journal: N Engl J Med Date: 2008-01-10 Impact factor: 91.245

10. Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis.

Authors: D Mark Davies; Simon R Johnson; Anne E Tattersfield; J Chris Kingswood; Jane A Cox; Deborah L McCartney; Tim Doyle; Frances Elmslie; Anand Saggar; Petrus J de Vries; Julian R Sampson
Journal: N Engl J Med Date: 2008-01-10 Impact factor: 91.245

8 in total

1. Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes.

Authors: Geoffrey R Oxnard; Binsheng Zhao; Camelia S Sima; Michelle S Ginsberg; Leonard P James; Robert A Lefkowitz; Pingzhen Guo; Mark G Kris; Lawrence H Schwartz; Gregory J Riely
Journal: J Clin Oncol Date: 2011-07-05 Impact factor: 44.544

Review 2. Drug development and clinical trials--the path to an approved cancer drug.

Authors: Eric H Rubin; D Gary Gilliland
Journal: Nat Rev Clin Oncol Date: 2012-02-28 Impact factor: 66.675

3. Clinical trials in the era of personalized oncology.

Authors: Michael L Maitland; Richard L Schilsky
Journal: CA Cancer J Clin Date: 2011-10-27 Impact factor: 508.702

4. Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome.

Authors: Maryam Aghighi; Justin Boe; Jarrett Rosenberg; Rie Von Eyben; Rakhee S Gawande; Philippe Petit; Tarsheen K Sethi; Jeremy Sharib; Neyssa M Marina; Steven G DuBois; Heike E Daldrup-Link
Journal: Radiology Date: 2016-03-16 Impact factor: 11.105

5. Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in Oncology.

Authors: Laurent Dercle; Dana E Connors; Ying Tang; Stacey J Adam; Mithat Gönen; Patrick Hilden; Sanja Karovic; Michael Maitland; Chaya S Moskowitz; Gary Kelloff; Binsheng Zhao; Geoffrey R Oxnard; Lawrence H Schwartz
Journal: JCO Clin Cancer Inform Date: 2018-12